Role of a-D-mannosidases in the biosynthesis and catabolism of glycoproteins
In mammalian cells mannose occurs predominantly in the different types of asparagine-linked oligosaccharide chains of glycoproteins. These chains are all derived from a common precursor, which is transferred from a lipid carrier to the growing polypeptide chain in the rough endoplasmic reticulum. During transport of the glycoproteins to their intracellular or extracellular destinations, the asparaginelinked oligosaccharides undergo modification in the endoplasmic reticulum and Golgi apparatus to yield the highmannose, hybrid and complex glycans found in mature glycoproteins (for a review see Kornfeld, 1982) . The enzymic hydrolysis of a-( 1 4 2), a-( 1 + 3), and a-( 1 +6) mannosidic linkages occurs during this processing. The a-Dmannosidases that catalyse these steps have very high substrate specificities and precise subcellular locations. The hydrolysis of a-( 1 +2), a-( 1 + 3) and a-( 1 +6) mannosidic linkages also occurs during the catabolism of endogenous and exogenous glycoproteins in the lysosomes. In view of the diverse functions and sites of hydrolysis of a-mannosidic linkages it is not surprising that multiple forms of a-Dmannosidase are present in mammalian cells.
Three structurally and genetically distinct types of mammalian a-D-mannosidase with different pH optima and subcellular locations have been described : acidic or lysosomal, intermediate or Golgi, and neutral or cytosolic a-D-mannosidase (Table 1) (Phillips et al., 1974a; Opheim & Touster, 1978; Hirani & Winchester, 1979; Bischoff & Kornfeld, 1983) . The three types of activity also differ in their kinetics, stability, sensitivity to activators and inhibitors, chromatographic properties and antigenicity. Multiple forms of the lysosomal and Golgi a-D-mannosidase can be separated by chromatography or centrifugation. The properties of the multiple forms of human a-D-mannosidase are reviewed and related to the properties of other mammalian a-D-mannosidases.
The activity-pH profile for the soluble a-D-mannosidase activity in human liver has two optima at pH4.0 and 6.5, suggesting the presence of two enzymic components. These activities can be separated by chromatography on concanavalin A-Sepharose (Phillips et a f . , 1976) . The a-D-mannosidase that does not bind to the lectin has a neutral pH optimum, whereas the activity that does bind has an acidic pH optimum. It has been shown for several species that the acidic and neutral a-D-mannosidases are located in the lysosomes and cytosol respectively (Suzuki et al., 1969; Marsh & Gourlay, 1971; Shoup & Touster, 1976) .
The human neutral a-D-mannosidase is labile, activated and stabilized by Co2+, and has a lower K , towards synthetic substrates than the Golgi and lysosomal a-mannosidases. It is also larger ( M , 50000&600000) than the other a-Dmannosidases and does not cross-react with antiserum raised against lysosomal a-D-mannosidase (Phillips et al., 1975) . It has been localized to chromosome 15 (Champion et al., 1978) , whereas lysosomal a-D-mannosidase is on chromosome 19 (Champion & Shows, 1977) . Rat-liver cytosolic a-Dmannosidase is also different from the Golgi and lysosomal a-D-mannosidases (Shoup & Touster, 1976) . Although purified rat-liver cytosolic a-D-mannosidase had been shown to hydrolyse the a-( 1 + 2), a-( 1 + 3) and a-( 1 4 6 ) mannosidic linkages in yeast oligosaccharides (Opheim & Touster, 1978) , the function of the enzyme was not evident. However, Bischoff & Kornfeld (1983) have recently described an a-D-mannosidase that is located predominantly in the endoplasmic reticulum of rat liver, but which is also present in a soluble form. It has a pH optimum of 6.5 and very similar properties to the cytosolic enzyme. It can catalyse the hydrolysis of a-( 1 +2) mannosidic linkages in high mannose oligosaccharides and is postulated to be responsible for the removal of mannose from asparaginelinked glycans in the endoplasmic reticulum before their entry into the Golgi apparatus. Thus the cytosolic a -~-mannosidase may arise from the integral endoplasmic reticulum membrane a-D-mannosidase by proteolysis or disruption during extraction.
The third type of a-D-mannosidase, which has a pH optimum intermediate between the acidic and neutral a-Dmannosidases, was first detected in human serum, where it is particularly abundant, by its sensitivity to Co2 + (Courtois & Mangeot, 1972) . It was subsequently found in rat (Dewald & Touster, 1973) , human (Phillips et al., 1974a) and bovine (Phillips et al., 19746) tissues. Centrifugation and extraction with detergents showed that intermediate a-D-mannosidase was located in the Golgi membranes of rat liver (Dewald & Touster, 1973) and other tissues (Tabas & Kornfeld, 1979; Forsee & Schutzbach, 1981) . Human fibroblast intermediate a-D-mannosidase, which can be separated into multiple forms by chromatography, can also be shown by free-flow electrophoresis or centrifugation to be located in the Golgi-endoplasmic-reticulum-membrane fraction (S. Hirani and B. Winchester, unpublished work) . Three forms of rat-liver Golgi a-D-mannosidase exist (Tulsiani et a/., 1977 Tabas & Kornfeld, 1979 GlcN Ac( Man),(GlcN Ac),Asn (Tabas & Kornfeld, 1978) and is active towards synthetic substrates, but not towards a-(1 -+ 2 ) linkages in oligosaccharides. a-D-Mannosidase 11 is distributed throughout the Golgi apparatus (Novikoff et al., 1983 ) whereas a-D-mannosidases Ia and Ib are concentrated in the cis cisternae (Dunphy et al., 1981) . a-D-Mannosidases la, Ib and I1 can all be separated into two forms by chromatography. It is not known whether this has any metabolic significance or whether the four a-( l 4 2)-linked mannosyl residues in high mannose chains and the a-( 1-3) and a-( 14) residues in the processing intermediate are removed in a particular order. Acidic a-D-mannosidase is involved in the lysosomal catabolism of glycoproteins, which is probably initiated by the action of lysosomal proteases. The breakdown of asparagine-linked oligosaccharides is believed to be initiated by the action of an endohexosaminidase on the chitobiosidic linkage in the common core region. Cleavage of the asparagine-N-acetylglycosamine linkage also occurs, but the sequence of early events in the catabolism of glycoproteins is not well understood. Subsequently monosaccharides are removed sequentially from the nonreducing end(s) of the oligosaccharide by the action of lysosomal exoglycosidases, including a-D-mannosidase. A deficiency of a lysosomal hydrolase results in the accumulation of partially catabolized metabolites, the pathological condition called a lysosomal storage disease. Thus lysosomal a-D-mannosidase has the capacity to hydrolyse a-( 1 4 2 ) , a-(1 +3) and ct-( I +6) mannosidic linkages. It is not known, whether one lysosomal a-D-mannosidase acts on all these linkages, or if there are several forms with different specificities, as with the processing a-D-mannosidases. This question has been studied by investigating (1) the structure of the mannosides that accumulate in human mannosidosis, the lysosomal storage disease resulting from the absence of lysosomal a-D-mannosidase, and (2) the specificity of purified lysosomal a-D-mannosidases.
Over 20 different oligosaccharides have been isolated from the urine of patients with mannosidosis (Norden et al., 1973 (Norden et al., , 1974 Strecker et al., 1976; Yamashita et al., 1980; Matsuura etal., 1981) . They all have a-(l-+2)-, a-(l+3)-or a-( 1 +6)-linked mannose residues at their non-reducing end(s) and a single N-acetylglucosamine residue at their reducing terminal. It is concluded therefore that normal lysosomal a-D-mannosidase can hydrolyse all three linkages. The expected storage product from the catabolism of complex glycans (which are generally more abundant),
Man(aI-3)[Man(aId)lMan(pl-4)
GlcNAc, is present only in trace amounts. Man(al-3)Man(pl-4)GlcNAc is the major storage product resulting from the incomplete catabolism of complex glycans. The core a-(1 +6)-linked mannosyl residue is also absent from the major storage product derived from high-mannose oligosaccharides, Man(a1-2)-Man(a 1 -3)Man(pl-4)GlcNAc. This suggests that the residual acidic a-D-mannosidase in mannosidosis (approximately 10%) hasactivitytowards thecore&( 1-4)mannosidic linkage. This activity could be a mutant form of the a-Dmannosidase affected in mannosidosis or another form of lysosomal a-Pmannosidase, which is unaffected in mannosidosis. The observations that the residual acidic a-Dmannosidase in mannosidosis cells does not cross-react with antiserum raised against normal human a-D-mannosidase and that no cross-reacting material is synthesized in mannosidosis cells, favours the latter suggestion (Burditt et al., 1978; Pohlmann et al., 1983) .
Two forms of human lysosomal cx-D-mannosidase, A and B, can be separated by chromatography on DEAE-cellulose (Carroll et al., 1972) . They have similar kinetic and physicochemical properties and are immunologically identical. Both forms are deficient in mannosidosis, showing that they are structurally and genetically related. This is consistent with a single locus for both forms on chromosome 19. They probably differ in their post-translational modification (Cheng et al., 1982) . Purified human-liver a-D-mannosidase A can completely remove one molecule of mannose from the main human storage product Man(al-3)Man(p1-4)-GlcNAc with a K , similar to that for synthetic substrates, but with a 10-fold greater V,,,. (Phillips et al., 1976) . The association of activity towards synthetic and natural substrates with a single enzymic protein justifies the use of synthetic substrates in the diagnosis of mannosidosis and defines the enzymic defect. Partially purified am-mannosidases A and B hydrolyse a-(1 +2), a-(1 4 3 ) and a-(1 4 6 ) linkages in several storage products (Hultberg et al., 1975) . Whether the substrate specificities of forms A and B are identical and the marked, but consistent, difference in proportions of the two forms in different tissues has any metabolic significance remain to be established.
Swainsonine, an indolizidine alkaloid originally isolated from plants of the genus Swainsona in Australia (Colegate et al., 1979 ) is a potent and specific inhibitor of a-Dmannosidase (Dorling et al., 1980) . Inhibition is probably due to its structural resemblance to the postulated transition state for the hydrolysis of mannosidic linkages. It is lysosomotropic, on account of its ~K~( 7 . 4 ) and induces a phenocopy of genetic mannosidosis in grazing or laboratory animals (Dorling et al., 1978) or ceIls in culture (Chotai et al., 1983; Dorling et al., 1983) . As swainsonine also inhibits neutral and Golgi a-D-mannosidase in uitro (Dorling et al., 1980; Elbein et al., 1981 ; Tulsiani et al., 1982b ) the nature of the storage products accumulating in swainsonine-induced mannosidosis can provide much information about the specificities of a-D-mannosidases.
Rats and guinea pigs fed a diet containing Swuznsona excrete large amounts of oligosaccharides of composition (Man),GlcNAc, suggesting that swainsonine has inhibited Golgi a-D-mannosidase 11 as well as the lysosomal a -~-mannosidase (Fig. 1) . Sheep excrete oligosaccharides of composition (Man)2 -,GlcNAc,, again showing that swainsonine has altered the processing of glycoproteins in uivo. The absence of oligosaccharides with more than five mannose residues shows that swainsonine does not inhibit the endoplasmic reticulum and Golgi a-D-mannosidases Ia and Ib, but does inhibit Golgi a-D-mannosidase 11. This agrees with data for the rat obtained in vitro (Tulsiani el al., 19826; Bischoff & Kornfeld, 1983) .
Swainsonine induces storage of oligosaccharides in normal human fibroblasts (Fig. 1) . The most abundant oligosaccharides are Man,GlcNAc and Man, -,GlcNAc. These compositions are consistent with inhibition of Golgi a-D-mannosidase I1 and Golgi a-D-mannosidase I or the endoplasmic reticulum activity respectively. Complex glycans formed before the blocking of processing by swainsonine are catabolized to Man,GlcNAc, rather than to Man,GlcNAc found in genetic mannosidosis. There is also a decrease in Man,GlcNAc and an increase in Man,Glc-N Ac in swainsonine-treated mannosidosis cells. These findings provide strong support for the existence of a lysosoma1 a-(1 4 6 ) mannosidase (form M), which is unaffected in mannosidosis, but is inhibited by swainsonine. They also suggest differences in the properties of the mannosidases or processing pathways between species.
The hydrolysis of a-D-mannosidic linkages in the biosynthesis and catabolism of glycoproteins is regulated by several a-D-mannosidases. The precise substrate specific- ities, subcellular locations, turnover and the significance of the multiple forms of a-D-mannosidase remain to be studied.
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